Upstate Active Clinical Trials
Study Title:A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TAVAPADON AS ADJUNCTIVE THERAPY FOR PARKINSON'S DISEASE IN LEVODOPA-TREATED ADULTS WITH MOTOR FLUCTUATIONS
What is the purpose of the study? (in Layman's terms, please describe the study)To assess the effect of tavapadon on the change from baseline in total daily hours of “on” time without troublesome
dyskinesia in L-Dopa-treated subjects with PD who are experiencing motor fluctuations.
Upstate Institutional Review Board (IRB) Number:1569679
Patient Age Group:Adults
Principal Investigator:Dragos L Mihaila
What is involved if I participate?
- How long is the study?
Approximately 7 months.
For more information about this trial go to ClinicalTrials.Gov
Who can I contact for more information?
Name: Marielle N Posmik